Marvel Medtech

Description

• Marvel Medtech's vision is to transform the clinical utility and productivity of MRI (Magnetic Resonance Imaging) by enabling interactive Magnetic Resonance Imaging-Guided Interventions (iMR-IGI). Marvel Medtechs novel Solada iMR-IGI technology platform is an advanced technology platform that integrates MRI-compatible robotics with real-time MR imaging techniques, thereby transforming the clinical utility of MRI from the limits of diagnostic imaging into a whole new realm of practical and effective interactive imaging-guided interventions. Marvel Medtech has raised a total of $2,250,000 of capital to date, including a $1.5 million federal Phase II SBIR grant program award from the National Cancer Institute/National Institutes of Health (NCI/NIH) in December 2014. The Company is presently seeking Series A equity financing of $6 million to supplement the Phase II SBIR grant award, and as matching funding required for submitting a Phase IIb NCI/NIH grant funding proposal of up to $3 million following completion of the Phase II project milestones. The objective over the next 12 months is to transform the proven concept technology into a clinically-usable, minimum viable product version of the Solada-T interventional tool positioning system, acquire FDA IDE approval, and place multiple systems at select European and U.S. sites to begin clinical evaluations.
• 

  Headquarters:1600 Aspen Commons , Middleton, Wisconsin, United States

  More
• 

  Phone Number: +1 608-442-9191

• 

  Website: https://www.marvelmedtech.com

• 

  Employees:2

• 

  Revenue:$0 - 1M

• 

  Legal Name:Marvel Medtech

• Marvel Medtech's Social Media

  
• Is this data correct?

• |  NAICS Code: 524128  |

  Show More